UnitedHealth Group Incorporated
UNHLast close · Oct 16, 2026401.43−5.24 (−1.29%)
Market cap$360.3B
12 firms' latest targets, last 90 days: median $500.00 ($402.00–$526.00), 25% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-16 | Stephens | $500.00 | — | +25% |
| 2026-10-16 | H.C. Wainwright | $500.00 | ▲ 2% | +25% |
| 2026-10-16 | Bernstein | $500.00 | ▲ 2% | +25% |
| 2026-10-15 | Raymond James | $450.00 | — | +12% |
| 2026-10-14 | Baird | $427.00 | ▼ 6% | +6% |
| 2026-10-14 | Piper Sandler | $504.00 | ▲ 6% | +26% |
| 2026-10-14 | Barclays | $440.00 | = 0% | +10% |
| 2026-10-09 | New Street | $402.00 | — | +0% |
| 2026-07-21 | BMO Capital | $512.00 | — | +28% |
| 2026-07-21 | D.A. Davidson | $512.00 | — | +28% |
| 2026-07-20 | Mizuho Securities | $493.00 | ▲ 7% | +23% |
| 2026-07-20 | Wells Fargo | $526.00 | ▲ 8% | +31% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $371.6B | +15% | $23.86 | +13% | est. $369.1B+1% | est. $24.96 | 13 |
| 2024reported | $400.3B | +8% | $15.51 | -35% | est. $401.0B+0% | est. $27.61 | 16 |
| 2025reported | $447.6B | +12% | $13.23 | -15% | est. $447.9B+0% | est. $16.32 | 18 |
| 2026 | $447.9B | +0% | $20.31 | +24% | $442.6B–$451.6B | $19.74–$20.87 | 18 |
| 2027 | $462.6B | +3% | $23.08 | +14% | $455.1B–$472.7B | $21.37–$24.52 | 18 |
| 2028 | $488.0B | +5% | $26.93 | +17% | $474.7B–$508.8B | $23.20–$28.95 | 20 |
| 2029 | $515.6B | +6% | $31.07 | +15% | $506.0B–$526.5B | $30.32–$31.92 | 10 |
| 2030 | $552.6B | +7% | $34.76 | +12% | $542.4B–$564.3B | $33.92–$35.71 | 10 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.